ETRACS UBS Bloomberg Constant Maturity Commodity Index (CMCI) Total Return ETN Series B due April 5, 2038 (UCIB)
Financial Services › National Commercial Banks
Price History
Feb 9, 2026 — Jul 6, 2026Investment Snapshot
- Trading 48% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 5/9 — moderate financial health
- ROE of 4.0% — below-average profitability
ETRACS UBS Bloomberg Constant Maturity Commodity Index (CMCI) Total Return ETN Series B due April 5, 2038 (UCIB) is a Financial Services company operating in National Commercial Banks, listed on the ARCA , with a market capitalisation of $125.3 billion . Key value metrics: P/E ratio 35.1, P/B ratio 1.41, Piotroski F-Score 5 out of 9 (moderate financial health) .
Value Score
Key Metrics
ETRACS UBS Bloomberg Constant Maturity Commodity Index (CMCI) Total Return ETN Series B due April 5, 2038 — Fundamental Analysis Summary
ETRACS UBS Bloomberg Constant Maturity Commodity Index (CMCI) Total Return ETN Series B due April 5, 2038 (UCIB) is currently trading 48% above its Graham Number of $21.92, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 35.1x.
On financial health, UCIB shows a moderate Piotroski F-Score of 5/9, and modest return on equity of 4.0% (sector average: 4.9%), and high leverage with a debt-to-equity ratio of 16.63.
StockPik's composite Value Score for UCIB is 52/100 — an above-average value rating. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
UCIB shows earnings growing at 133%.